with this current pps. Just its IPs alone woth much more than that, any ideas guys?
whyz, the IP isn't worth anything if the company does not have funds to go forward.
In BK all the IP reverts to NIH.
This is the risk here.
Take your choice
(A) Insiders shorting the price down for the next privileged offering to their banker budds............
(B) JJ enjoys playing "hide and seek" with pertinent info on a "publicly held" company (3 new patents and changed trial design)
(C) Sno's right and M. Bove (Sigma, Lee's board, and RGRX's board) is throwing in the towel after all these years of chess moves and letting NIH (US GVT) repo the IP and patents
So Donker, iyo how much it worhs? thanks